Using PDGF-β as a mesangial cell marker [22], we observed an expansion of mesangial cells in the glomeruli of diabetic nephropathy mice but an inhibition of this expansion in diabetic nephropathy mice treated with VPA (Figure 5: DN + VPA). Here, PDGFB is linked to diabetic kidney disease.